Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JG, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C.

J Clin Oncol. 2007 Apr 1;25(10):1239-46. Erratum in: J Clin Oncol. 2007 Aug 20;25(24):3790.

PMID:
17401012
2.

Challenges in projecting clustering results across gene expression-profiling datasets.

Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23.

PMID:
18000217
3.

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.

PMID:
16478745
4.

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

Bianchini G, Qi Y, Alvarez RH, Iwamoto T, Coutant C, Ibrahim NK, Valero V, Cristofanilli M, Green MC, Radvanyi L, Hatzis C, Hortobagyi GN, Andre F, Gianni L, Symmans WF, Pusztai L.

J Clin Oncol. 2010 Oct 1;28(28):4316-23. doi: 10.1200/JCO.2009.27.2419. Erratum in: J Clin Oncol. 2010 Nov 10;28(32):4868. J Clin Oncol. 2012 Feb 20;30(6):679.

PMID:
20805453
5.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
6.

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.

J Clin Oncol. 2006 Apr 10;24(11):1656-64.

PMID:
16505416
7.

The genomic profile of HER2-amplified breast cancers: the influence of ER status.

Marchiò C, Natrajan R, Shiu KK, Lambros MB, Rodriguez-Pinilla SM, Tan DS, Lord CJ, Hungermann D, Fenwick K, Tamber N, Mackay A, Palacios J, Sapino A, Buerger H, Ashworth A, Reis-Filho JS.

J Pathol. 2008 Dec;216(4):399-407. doi: 10.1002/path.2423.

PMID:
18810758
8.

Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?

Loi S.

Eur J Cancer. 2008 Dec;44(18):2813-8. doi: 10.1016/j.ejca.2008.09.012. Review.

PMID:
18990560
9.

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

Breast Cancer Res. 2008;10(4):R65. doi: 10.1186/bcr2124.

10.

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.

Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM.

Clin Cancer Res. 2007 Apr 15;13(8):2329-34.

11.

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32.

PMID:
18037662
12.

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R, Perracchio L, Venturo I, Nisticò C, Fabi A, Buglioni S, Natali PG, Mottolese M.

Breast Cancer Res. 2008;10(5):R74. doi: 10.1186/bcr2139.

13.

[Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].

Chanrion M, Darbon JM.

Bull Cancer. 2008 May;95(5):513-8. doi: 10.1684/bdc.2008.0646. Review. French.

14.

Understanding the molecular basis of histologic grade.

Ignatiadis M, Sotiriou C.

Pathobiology. 2008;75(2):104-11. doi: 10.1159/000123848. Review.

PMID:
18544965
15.

GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.

Voduc D, Cheang M, Nielsen T.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):365-73. doi: 10.1158/1055-9965.EPI-06-1090.

16.

Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.

Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C.

Clin Cancer Res. 2008 Aug 15;14(16):5158-65. doi: 10.1158/1078-0432.CCR-07-4756.

17.

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.

Toussaint J, Sieuwerts AM, Haibe-Kains B, Desmedt C, Rouas G, Harris AL, Larsimont D, Piccart M, Foekens JA, Durbecq V, Sotiriou C.

BMC Genomics. 2009 Sep 10;10:424. doi: 10.1186/1471-2164-10-424.

18.

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.

Kok M, Linn SC, Van Laar RK, Jansen MP, van den Berg TM, Delahaye LJ, Glas AM, Peterse JL, Hauptmann M, Foekens JA, Klijn JG, Wessels LF, Van't Veer LJ, Berns EM.

Breast Cancer Res Treat. 2009 Jan;113(2):275-83. doi: 10.1007/s10549-008-9939-y.

PMID:
18311582
19.

A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

Yu K, Ganesan K, Miller LD, Tan P.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3288-96.

20.

Predicting features of breast cancer with gene expression patterns.

Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X, Richardson AL.

Breast Cancer Res Treat. 2008 Mar;108(2):191-201. doi: 10.1007/s10549-007-9596-6.

PMID:
18297396

Supplemental Content

Support Center